Abstract

A major limitation of conventional chemotherapies used in cancer treatments today are low therapeutic indices and side effects that result from drug effects on normal tissues (off target). One of the most innovative approaches to developing antineoplastic agents with increased tumor selectivity is the use of suicide gene therapy. Suicide gene therapy involves delivering a gene product in proximity to the targeted cancer tissue through various targeted delivery methods followed by tissue/tumor-specific expression of the gene product which then converts a systemically available pro-drug into an active drug within the tumor locale. Here we summarize the concept of gene therapy for cancer and introduce the most frequently used suicide gene therapy systems. In addition we discuss viral, molecular and cellular vectors and their advantages and disadvantages. Finally, we describe the clinical applications, limitations and potential side effects of suicide gene therapy to date.

Highlights

  • Cancer and its treatment are an immense burden on the individual patient and on the entire healthcare system

  • Despite some improvements in outcomes of cancer patients, the high rate of cancer related deaths and overall rising incidence of cancer highlights some of the limitations of conventional cancer treatment strategies such as chemotherapy, radiotherapy and surgical resection

  • Chemotherapy has long been the cornerstone of cancer treatment [2]

Read more

Summary

Suicide Gene Therapy against Cancer

Z Keung and Claudius Conrad1* 1Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA 2Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA 3Medizinische Klinik und Poliklinik IV, AG Biochemistry, University of Munich, Munich, Germany

Introduction
Suicide Gene Therapy of Cancer
Suicide Gene Systems for Cancer Therapy
Horseradish peroxidase Carboxypeptidase A
Free radicals MTX
Targeted Delivery of Suicide Genes
Viral vectors
Molecular vectors
Cellular vector
Clinical Applications
Glioblastoma Multiforme
Gastrointestinal Cancer
Prostate Cancer
Gynecologic Cancers
Limiting Factors
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.